When Francisco Leon talks about the medical science behind the biotech company he founded in 2023, it sounds like something out of a movie. The company, Tolerance Bio, focuses on preserving the body’s ...
INmune Bio (NASDAQ:INMB) announced on Monday a partnership with U.K.-based drug technology organization Cell and Gene Therapy Catapult to expand the manufacturing capabilities for its pipeline of cell ...
Extending human health span by several years is the vision of clock.bio, a biotech startup that is investigating the biology of cellular rejuvenation. The company recently raised $5.3 million in seed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback